SPON2 and colorectal carcinoma: Some scholars have identified through genome-wide expression analysis that SPON2, as one of the major downstream effectors of MACC1 gene, can be used as an independent prognostic indicator for CRC metastasis and metastasis-free survival (MSF) [12].